BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1400761)

  • 1. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase.
    Noctor TA; Wainer IW; Hage DS
    J Chromatogr; 1992 Jun; 577(2):305-15. PubMed ID: 1400761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography.
    Aubry AF; Markoglou N; McGann A
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Nov; 112(3):257-66. PubMed ID: 8838677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate.
    Bertucci C
    Chirality; 2001 Jul; 13(7):372-8. PubMed ID: 11400191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites.
    Domenici E; Bertucci C; Salvadori P; Wainer IW
    J Pharm Sci; 1991 Feb; 80(2):164-6. PubMed ID: 2051322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
    Dubois N; Lapicque F; Abiteboul M; Netter P
    Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin.
    Rahman MH; Yamasaki K; Shin YH; Lin CC; Otagiri M
    Biol Pharm Bull; 1993 Nov; 16(11):1169-74. PubMed ID: 8312878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective binding of ketoprofen enantiomers to human serum albumin studied by high-performance liquid affinity chromatography.
    Zhivkova ZD; Russeva VN
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):277-83. PubMed ID: 9766867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions.
    Domenici E; Bertucci C; Salvadori P; Motellier S; Wainer IW
    Chirality; 1990; 2(4):263-8. PubMed ID: 2083149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of octanoic acid on the reversible protein binding of ketorolac enantiomers to human serum albumin (HSA): comparative liquid chromatographic studies using a HSA chiral stationary phase.
    Hayball PJ; Holman JW; Nation RL
    J Chromatogr B Biomed Appl; 1994 Dec; 662(1):128-33. PubMed ID: 7894686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin.
    Bertucci C; Canepa A; Ascoli GA; Guimaraes LF; Felix G
    Chirality; 1999; 11(9):675-9. PubMed ID: 10506426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural investigations of stereoselective profen binding by equine and leporine serum albumins.
    Zielinski K; Sekula B; Bujacz A; Szymczak I
    Chirality; 2020 Mar; 32(3):334-344. PubMed ID: 31905261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the magnitude and enantioselectivity of ligand binding to rat and rabbit serum albumins using immobilized-protein high performance liquid chromatography stationary phases.
    Massolini G; Aubry AF; McGann A; Wainer IW
    Biochem Pharmacol; 1993 Oct; 46(7):1285-93. PubMed ID: 8216380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of sulindac competition with specific markers for the major binding sites on human serum albumin.
    Russeva VN; Zhivkova ZD
    Arzneimittelforschung; 2003; 53(3):174-81. PubMed ID: 12705172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin.
    Diana FJ; Veronich K; Kapoor AL
    J Pharm Sci; 1989 Mar; 78(3):195-9. PubMed ID: 2724076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group.
    Maruyama T; Lin CC; Yamasaki K; Miyoshi T; Imai T; Yamasaki M; Otagiri M
    Biochem Pharmacol; 1993 Mar; 45(5):1017-26. PubMed ID: 8461031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of coumarins to site I of human serum albumin. Effect of the fatty acids.
    Zatón AM; Ferrer JM; Ruiz de Gordoa JC; Marquínez MA
    Chem Biol Interact; 1995 Jul; 97(2):169-74. PubMed ID: 7606814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.